Julie Lamb, Senior Editor

About the Author Julie Lamb, Senior Editor

Julie joined Smarter Analyst across the world- all the way from Louisville, Kentucky- where she graduated with a Bachelor of Arts in English with a focus on creative writing from the University of Louisville.

This Bull Sees a Bright Future Ahead for Square Inc; Here’s Why

Nomura’s Dan Dolev’s strong bullish call and price target jump on Square stock is sending shares rising 5% in trading today.

Could Hospitals Making Generic Assets Impact Teva Pharmaceutical Industries Ltd (ADR) and Endo International plc? Analysts Answer

A NYT article has Wall Street abuzz today with whispers of non-profit hospital groups creating a new generics maker or partnering with third party manufacturers.

Don’t Get Jittery on Valeant Pharmaceuticals Intl Inc Just Because of Prospective Cosmo Rivalry, Argues Louise Chen

Cantor’s Louise Chen dismisses Valeant share weakness today, making a bullish case that the majority of Xifaxan’s sales stem from IBS-D; not Traveler’s Diarrhea.

Juno Therapeutics Inc May Be the Ideal Takeout Target for a Large Pharma like Celgene: Jason McCarthy

In reaction to acquisition buzz in the market’s grapevine, Maxim’s Jason McCarthy is out boosting his price target on Juno stock.

Advanced Micro Devices, Inc.’s and NVIDIA Corporation’s Crypto-Mania May Be Nearing Its End: Christopher Rolland

Crypto-related GPU sales appear to be more massive than AMD and NVDA had expected in 4Q17; here’s why Susquehanna’s Christopher Rolland says this could be an issue.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Just Lost a Bull

Though BTIG’s Tim Chiang sees a recovery in the works for TEVA, he sees shares as “fairly valued” at currently levels.

International Business Machines Corp. (IBM): Buy the Dip or Pump the Brakes?

Oppenheimer’s Ittai Kidron asks where can IBM “go from here” following two consecutive years of gross margin downturns in every segment?

All Eyes on International Business Machines (IBM) 4Q Earnings Tonight

Cantor’s Joseph Foresi highlights some positives in IBM’s favor approaching tonight’s quarterly results, but still sees more downside risk than upside gain to shares.

QUALCOMM, Inc. (QCOM) Wins Over New Confidence from Christopher Rolland

Susquehanna’s Christopher Rolland boosts his price target on QCOM stock on back of $1 billion cost reduction initiative.

Analyst Sees Optimism on Kinder Morgan Inc (KMI) into 2018 on Back of Improving G&P Segment

RBC Capital’s Elvira Scotto projects 15% in return potential for KMI stock following the 4Q earnings showcase.

Show More